Arca
Skip to content
Tools
Tools

Sepsis

Drug research and approvals for sepsis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 381 studies of sepsis are recruiting on ClinicalTrials.gov, Health Canada has authorized 15 drug trials for it since 2013, and FDA has 0 approved and 4 open orphan designations naming it.

  • Recruiting worldwide: 381
  • Trials authorized in Canada: 15
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 381 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 13

Phase 3 12 of 38

Phase 2 12 of 23

Phase 1 or earlier 12 of 22

How its trials ended

1,566 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 277 whose ending is known, 31% met their primary endpoint, 16% missed it and 53% stopped early.

  • Completed, result not reported63541%
  • Status unknown33822%
  • Ongoing31620%
  • Met its primary endpoint865%
  • Stopped: other or unclear835%
  • Missed its primary endpoint433%
  • Stopped: enrollment or feasibility403%
  • Stopped: lack of efficacy101%
  • Stopped: funding6<1%
  • Stopped: sponsor or business decision5<1%
  • Stopped: safety4<1%

Trials authorized in Canada

The 10 newest of 15; search them all in Canada trials
Dec 15, 2025Beta-blocker therapy versus standard care in patients with septic shock: a pilot randomized controlled trial utilizing predictive enrichment with point-of-care…EsmololLondon Health Sciences CentreOngoing
Jul 15, 2025The nicu antibiotics and outcomes trial (NANO)Ampicillin / GentamicinThe Governors of The University of AlbertaClosed
Sep 20, 2023Amulticenter, randomized, double-blind, placebo-controlled, four-arm, parallel-group, dose-finding, phase 2b study to investigate the safety and efficacy of…TIN816Novartis PharmaceuticalsClosed
Nov 30, 2022Intravenous dnase i for the treatment of sepsis: a phase I safety and feasibility study in icu patientsPulmozymeMcMaster UniversityOngoing
Mar 9, 2022Energy metabolism of septic heartPalmitate 11C / Actetate 11C / CyclodxCiusss De L'Estrie - Centre Hospitalier Universitaire De SherbrookePending
Apr 26, 2021Pragmatic pediatric trial of balanced versus normal saline fluids in sepsis (prompt bolus)Plasma-lyte a/ Lactated ringer's/ Sodium chlorideGovernors of The University of CalgaryOngoing
Mar 3, 2021The amethyst trial - advanced mesenchymal enhanced cell therapy for septic patientsCryopreserved, genetically modified allogeneic mesenchymal stromal cellsNorthern Therapeutics Inc.Closed
Sep 11, 2020A randomized, double-blind, placebo-controlled, two-arm parallel-group, multi-center phase 3 pivotal trial to investigate the efficacy and safety of…Recombinant human alkaline phosphatase (RECAP)Am-Pharma B.V.Closed
Jun 5, 2020Lessening organ dysfunction with vitamin C ¿ covid (lovit-covid)Vitamin CCentre De Recherche Du Centre Hospitalier Universitaire De SherbrookeOngoing
Nov 22, 2018A crossover, cluster randomised controlled trial of selective decontamination of the digestive tract in intensive care unit patients (SUDDICU)Nystatin-colistin-tobramycinSunnybrook Research InstituteClosed

FDA orphan designations

Approved first, then open designations, newest first
Feb 19, 2015Bovine lactoferrinPrevention of late-onset sepsis in very low birth weight infantsMetrodora Therapeutics, LLCDesignated
Aug 3, 2000Chimeric, humanized monoclonal antibody to staphylococcusProphylaxis of Staphylococcus epidermidis sepsis in low birth weight (1500 grams or less) infants.Biosynexus, Inc.Designated
Dec 20, 1993BeractantTreatment of full-term newborn infants with respiratory failure caused by meconium aspiration syndrome, persistent pulmonary hypertension…Ross LaboratoriesDesignated
Nov 4, 1985Monoclonal antiendotoxin antibody XMMEn-0e5Treatment of patients with gram-negative sepsis which has progressed to shock.Pfizer, Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.